APA (7th ed.) Citation

TT, W., YY, C., ZC, Y., GW, Y., & GL, Z. (2024). Synergy of de-walled Ganoderma Lucidum spore powder (GLSP) on targeted therapy in advanced non-squamous non-small cell lung cancer with epidermal growth factor receptor (EGFR) mutant: Protocol for a randomized, double-blind, placebo-controlled study. BMC complementary medicine and therapies, 24(1), 125. https://doi.org/10.1186/s12906-024-04416-2

Chicago Style (17th ed.) Citation

TT, Wu, Chen YY, Yuan ZC, Yang GW, and Zhang GL. "Synergy of De-walled Ganoderma Lucidum Spore Powder (GLSP) on Targeted Therapy in Advanced Non-squamous Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Mutant: Protocol for a Randomized, Double-blind, Placebo-controlled Study." BMC Complementary Medicine and Therapies 24, no. 1 (2024): 125. https://doi.org/10.1186/s12906-024-04416-2.

MLA (9th ed.) Citation

TT, Wu, et al. "Synergy of De-walled Ganoderma Lucidum Spore Powder (GLSP) on Targeted Therapy in Advanced Non-squamous Non-small Cell Lung Cancer with Epidermal Growth Factor Receptor (EGFR) Mutant: Protocol for a Randomized, Double-blind, Placebo-controlled Study." BMC Complementary Medicine and Therapies, vol. 24, no. 1, 2024, p. 125, https://doi.org/10.1186/s12906-024-04416-2.